Xyosted 50 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F1FQJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,211
Award facts
- Contract value 100% obligated
- $1,211.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xyosted 50 mg/0.5 mL auto-injector units valued at $1,211.12. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by November 14, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999.99 billion and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's performance under the SPE2DX contract demonstrates its capability to fulfill diverse federal medical supply requirements through open competition, delivering products ranging from specialty medications and vaccines to medical devices and auto-injectors across multiple therapeutic domains. This delivery order for testosterone replacement therapy represents a routine pharmaceutical procurement supporting military medical readiness.
Quick answers
Who was awarded contract SPE2DR26F1FQJ?
SPE2DR26F1FQJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F1FQJ worth?
The government has obligated $1,211 on SPE2DR26F1FQJ.
Is contract SPE2DR26F1FQJ an order under another contract?
Yes. SPE2DR26F1FQJ is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1FQJ competed?
The extent of competition for SPE2DR26F1FQJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award